(1 reference)-
- 抗原 See all Lrig1 抗体
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
抗原表位
- AA 801-829, C-Term
-
适用
- 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Lrig1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- 免疫原
- This LRIG1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 801-829 amino acids from the C-terminal region of human LRIG1.
- 克隆位点
- RB40253
- 亚型
- Ig Fraction
- Top Product
- Discover our top product Lrig1 Primary Antibody
-
anti-Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1) (AA 1001-1093) antibody
Lrig1 适用: 人, 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1) (AA 35-220) antibodyLrig1 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1) antibodyLrig1 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1) (AA 35-220) antibodyLrig1 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1) (AA 739-995) antibodyLrig1 适用: 人 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1) (AA 801-829) antibodyLrig1 适用: 小鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB: 1:1000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 有效期
- 6 months
-
-
: "Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity." in: Journal of neuro-oncology, Vol. 94, Issue 2, pp. 183-94, (2009) (PubMed).
-
: "Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity." in: Journal of neuro-oncology, Vol. 94, Issue 2, pp. 183-94, (2009) (PubMed).
-
- 抗原
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
- 别名
- LRIG1 (Lrig1 产品)
- 别名
- LIG-1 antibody, LIG1 antibody, D6Bwg0781e antibody, Img antibody, leucine rich repeats and immunoglobulin like domains 1 antibody, leucine-rich repeats and immunoglobulin-like domains 1 antibody, LRIG1 antibody, Lrig1 antibody
- 背景
- LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
- 分子量
- 119113
- NCBI登录号
- NP_056356
- UniProt
- Q96JA1
-
You are here:
